Frestedt Inc. is Proud to Announce the Promotion of Dr. Linnea Schmidt
Frestedt Inc. is pleased to announce the promotion of Dr. Linnea Schmidt to the position of CRQE II. In this position Dr. Schmidt will be taking on more responsibility for many of the clinical, regulatory, quality and engineering projects at Frestedt Inc. Dr. Schmidt notices many FDA slide decks emphasize past safety issues with drugs and devices intended for women and expresses desire to work on more women’s health issues especially related to issues of safety and appropriate labeling for drugs, devices and foods used by women. In the past two years, Dr. Schmidt has updated many drug labels to be compliant with the regulatory final rule entitled Content and Format of Labeling for Human Prescription Drug and Biological Products:Requirements for Pregnancy and Lactation Labeling, which is also known simply as the “Pregnancy and Lactation Labeling Rule” (PLLR), published in December 2014.